Discover and read the best of Twitter Threads about #DAPA
Most recents (10)
Follow this #CardioTwitter #Thread
to get an overview of ALL
🚨#ESCcongress #HotLineSessions🚨
Including:
➡️14 #OnePager #CongressCards
➡️Links to on-demand stream
➡️Jorunal weblinks
➡️Hashtag of the author/presenter
PART 1 ⬇️
to get an overview of ALL
🚨#ESCcongress #HotLineSessions🚨
Including:
➡️14 #OnePager #CongressCards
➡️Links to on-demand stream
➡️Jorunal weblinks
➡️Hashtag of the author/presenter
PART 1 ⬇️
1.1./ #TIME trial - The Treatment in Morning versus Evening study.
📕🔗:: NOT YET PUBLISHED
On-demand ESC 📺: bit.ly/3AQuvkB
#ESCcongress
📕🔗:: NOT YET PUBLISHED
On-demand ESC 📺: bit.ly/3AQuvkB
#ESCcongress
1) Welcome to our new #accredited #tweetorial which is Part 1 of a 2-part "highlights" program on new #SGLT2i & #DKD data presented at @ERAkidney #ERA22. #Physicians #nurses #pharmacists #PAs and #NPs can all earn 0.5h CE/#CME by following this thread!
2) @ERAkidney #ERA22 is a primary international scientific symposium for interaction and exchange among basic scientists and clinicians working in #Nephrology. It was held in May. Our expert author is Dr. Sheila Bermejo (@shbermejo) from @vallhebron in Barcelona, Spain.
3) This program is #accredited for CE/#CME & is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance. It is not intended for US- or UK-based based HCPs. Accreditation statement & faculty disclosures at ckd-ce.com/disclosures/.
1) Welcome to a new #accredited #tweetorial on Cardiorenal Disease in T2D & the Impact of Blocking the MR in Patients w/DKD, another CE/#CME program by one of the @GoggleDocs, this time our friend @AmarPut, Diabetes & Endocrine Consultant in the West Midlands 🇬🇧. #CaReMe #FOAMed
2) This program is supported by an educational grant from Bayer & is intended for #healthcare providers. Author disclosures can be found at ckd-ce.com/disclosures/. Prior programs, still available for CE/#CME credit, are at ckd-ce.com. CE/#CME credit 🇬🇧🇪🇺🇨🇦🇺🇸
3) So first – the ‘triple threat’ . . . We know of the link between the 🫀 and the kidneys and the ‘#cardiorenal’ syndrome, but what about in the setting of #diabetes?
1) Welcome to a new #accredited #tweetorial from our good friends and #diabetes experts @GoggleDocs, specifically @drkevinfernando, @drpatrickholmes, & @AmarPut. They have put their 🗣️s together to provide us with a summary of the first-ever consensus statement from ...
2) ... @AmDiabetesAssn & @goKDIGO, which were discussed at the recently concluded #isnwcn congress in Kuala Lumpur. This joint document nicely summarizes important recent advances and practice-changing data for the management of diabetic #kidneydisease #DKD.
3) This program is #accredited for CE/#CME #physicians #physicianassociates #nurses #pharmacists #nursepractitioners & is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance. It is not intended for US based healthcare professionals.
Join us tomorrow for the launch of a new accredited tweetorial – a case-based program on the assessment and management of patients with IgA #nephropathy (#IgAN). Free CE/#CME for #physicians, #nurses, #pharmacists! Expert author none other than @IgAN_JBarratt. FOLLOW US . . .
. . . and tell your colleagues to join you here on @ckd_ce, your ONLY source for accredited #tweetorials in the #CKD space! #nephtwitter #nephjc @nephondemand @Nephro_Sparks @edgarvlermamd @ChristosArgyrop @goKDIGO @nicklimd @CKJsocial @ERAkidney @kidney_boy @kidneypathology
1) Welcome to our accredited #tweetorial on optimal contemporary mgt of #IgAN. Earn 0.5h CME/CE credit #physicians #nurses #nursepractitioners #physicianassistants by following this thread. I am @IgAN_JBarratt. @MedTweetorials #nephtwitter #nephjc #FOAMed #MedEd
📌 Controversies in #HeartFailure
SGLT2 Inhibitors Should Be Given to All Patients⁉️
What is the best glucose lowering therapy to treat T2D in👥with #HFpEF⁉️
Prof. McMurray
#ESCCongress
@paomorejon @ESC_Lavinia @escardio @ShelleyZieroth @hvanspall @HanCardiomd @MihaiTrofenciuc
SGLT2 Inhibitors Should Be Given to All Patients⁉️
What is the best glucose lowering therapy to treat T2D in👥with #HFpEF⁉️
Prof. McMurray
#ESCCongress
@paomorejon @ESC_Lavinia @escardio @ShelleyZieroth @hvanspall @HanCardiomd @MihaiTrofenciuc
📌 SGLT2 Inhibitors Should Be Given to All Patients⁉️
#DAPA -HF
Not representative of all HF
Subgroups where iSGLT2 don’t work
👥were undertreated
Prof. De Boer
#ESCCongress
@paomorejon @escardio
#DAPA -HF
Not representative of all HF
Subgroups where iSGLT2 don’t work
👥were undertreated
Prof. De Boer
#ESCCongress
@paomorejon @escardio
📌 SGLT2 Inhibitors Should Be Given to All Patients⁉️
We aren’t making changes
#ESCCongress
@paomorejon @escardio
We aren’t making changes
#ESCCongress
@paomorejon @escardio
Day-2 #ESCCongress 🗣 Breaking #DAPA-#CKD Impressive Results:
Significant Reduction of Renal & CV outcomes
All the Secondary EPs reduced included All-cause 💀
@GiuseppeGalati_ @radcliffeCARDIO @MicheleSenni @SABOURETCardio @zhh_ch @DrMarthaGulati @mmamas1973 @AstraZeneca
Significant Reduction of Renal & CV outcomes
All the Secondary EPs reduced included All-cause 💀
@GiuseppeGalati_ @radcliffeCARDIO @MicheleSenni @SABOURETCardio @zhh_ch @DrMarthaGulati @mmamas1973 @AstraZeneca
☝️#DAPA-#CKD The impressive Results are independent od Diabetes status
#ESCCongress @GiuseppeGalati_
@rahatheart1 @KTamirisaMD @AndreasGevaert @lucreciamburgos @DocSavageTJU @markcpetrie20 @HeartOTXHeartMD @UshyMohanDas
@hfcollaboratory @HeartFailureFrm @SABOURETCardio
#ESCCongress @GiuseppeGalati_
@rahatheart1 @KTamirisaMD @AndreasGevaert @lucreciamburgos @DocSavageTJU @markcpetrie20 @HeartOTXHeartMD @UshyMohanDas
@hfcollaboratory @HeartFailureFrm @SABOURETCardio
☝️#DAPA-#CKD Dapaglifozin is effective and safe in #CKD
#ESCCongress @GiuseppeGalati_
@rahatheart1 @KTamirisaMD @AndreasGevaert @DrRajivsankar @radcliffeCARDIO @mirvatalasnag @DrMarthaGulati @UoGHeartFailure @BSHeartFailure @AnnaKateBarton @iamritu @purviparwani @DrRaniKhatib
#ESCCongress @GiuseppeGalati_
@rahatheart1 @KTamirisaMD @AndreasGevaert @DrRajivsankar @radcliffeCARDIO @mirvatalasnag @DrMarthaGulati @UoGHeartFailure @BSHeartFailure @AnnaKateBarton @iamritu @purviparwani @DrRaniKhatib
Day-2 #ESCCongress Prof McMurray doing an head to head comparison of #DAPA-HF vs #Emperor-Reduced
Trying to explain different #CV-death results
@GiuseppeGalati_ @radcliffeCARDIO @MicheleSenni @SABOURETCardio @zhh_ch @DrMarthaGulati @mirvatalasnag @HFA_President @AstraZeneca
Trying to explain different #CV-death results
@GiuseppeGalati_ @radcliffeCARDIO @MicheleSenni @SABOURETCardio @zhh_ch @DrMarthaGulati @mirvatalasnag @HFA_President @AstraZeneca
☝️ Probably the lower #CV-death recorded in #Emperor-reduced is secondary to the shorter mean follow-up per McMurray opinion (16 vs 18.2 months of #DAPA-HF)
#ESCCongress @GiuseppeGalati_ @KTamirisaMD @DrNasrien @lucreciamburgos @DocSavageTJU @MedAxiom @DrRajivsankar @Dr_Manito
#ESCCongress @GiuseppeGalati_ @KTamirisaMD @DrNasrien @lucreciamburgos @DocSavageTJU @MedAxiom @DrRajivsankar @Dr_Manito
☝️ #ESCCongress McMurray
However, the most important result is the consistent reduction of primary #EP as SGLT2i class effect!
#Emperor-reduced #DAPA-HF
@GiuseppeGalati_
@HeartFailureFrm @HFA_President @CircHF @DrRajivsankar @Dr_Manito
@JTLLERGO @eSPACEHF @UoGHeartFailure
However, the most important result is the consistent reduction of primary #EP as SGLT2i class effect!
#Emperor-reduced #DAPA-HF
@GiuseppeGalati_
@HeartFailureFrm @HFA_President @CircHF @DrRajivsankar @Dr_Manito
@JTLLERGO @eSPACEHF @UoGHeartFailure
Five yrs ago today, Pres. Obama announced his plan to provide DACA-like protections to some undocumented parents of U.S. citizens and residents.
Watching this again today, it feels like it may as well have been 50.
RIP, #DAPA
Watching this again today, it feels like it may as well have been 50.
RIP, #DAPA
All of this is only more true than it ever was.
All of it will still be true five years from now.
All of it will still be true five years from now.
Unlike any of Trump's executive orders, #DAPA was the product of many months of careful study and coordination across several agencies. There were lengthy internal debates about the best approach to the goal at hand, with a special view to legality. And yet.
Day2: #ESCCongress #BreakingNews Dr McMurray 🔥🎉#DAPA-HF: In #HFrEF NYHA II-III #Dapaglifozin reduced #CVDeath #HFHospitalization & secondary EP #AllCauseDeath #WorseningHF , Improved QoL with a highly safety profille
@GiuseppeGalati @mmamas1973
@ShelleyZieroth @SABOURETCardio
@GiuseppeGalati @mmamas1973
@ShelleyZieroth @SABOURETCardio
☝️#ESCCongress Comment by Prof @MarcoMetra This is a mew molecule & a new hope for our pts @GiuseppeGalati_ @ShelleyZieroth @hvanspall @paomorejon @DrMarthaGulati @lamcardio @HFA_President @DrLadyMaria1 @sarahhudsonuk @TomLuscher @lanzule @mmamas1973 @MihaiTrofenciuc
☝️#ESCCongress. Here #DAPA-HF design, Baseline Pop characteristics & Treatment.
We need to underline a little % of sac/val in #HFrEF pts @GiuseppeGalati_ @ShelleyZieroth @hvanspall @paomorejon @MihaiTrofenciuc @DrMarthaGulati @lamcardio @MarcoMetra @lanzule @mmamas1973 @escardio
We need to underline a little % of sac/val in #HFrEF pts @GiuseppeGalati_ @ShelleyZieroth @hvanspall @paomorejon @MihaiTrofenciuc @DrMarthaGulati @lamcardio @MarcoMetra @lanzule @mmamas1973 @escardio
